Which has preferable earnings and valuation, AEMD or AMIX?

Autonomix Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aethlon Medical N/A N/A -$7.15M -$34.97 N/A Autonomix Medical N/A N/A -$16.72M -$41.57 N/A

Is AEMD or AMIX more profitable?

Aethlon Medical's return on equity of -123.08% beat Autonomix Medical's return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -123.08% -99.28% Autonomix Medical N/A -267.73% -216.75%

Does the media prefer AEMD or AMIX?

In the previous week, Aethlon Medical had 2 more articles in the media than Autonomix Medical. MarketBeat recorded 9 mentions for Aethlon Medical and 7 mentions for Autonomix Medical. Aethlon Medical's average media sentiment score of 1.02 beat Autonomix Medical's score of 0.91 indicating that Aethlon Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Autonomix Medical 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is AEMD or FEMY more profitable?

Aethlon Medical has a net margin of 0.00% compared to Femasys' net margin of -534.36%. Aethlon Medical's return on equity of -123.08% beat Femasys' return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -123.08% -99.28% Femasys -534.36% -225.97% -74.68%

Does the media prefer AEMD or FEMY?

In the previous week, Aethlon Medical had 2 more articles in the media than Femasys. MarketBeat recorded 9 mentions for Aethlon Medical and 7 mentions for Femasys. Aethlon Medical's average media sentiment score of 1.02 beat Femasys' score of 0.53 indicating that Aethlon Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Femasys 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable valuation and earnings, AEMD or NDRA?

ENDRA Life Sciences is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aethlon Medical N/A N/A -$7.15M -$34.97 N/A ENDRA Life Sciences N/A N/A -$7.03M -$6.38 N/A

Is AEMD or NDRA more profitable?

Aethlon Medical's return on equity of -123.08% beat ENDRA Life Sciences' return on equity. Company Net Margins Return on Equity Return on Assets Aethlon Medical N/A -123.08% -99.28% ENDRA Life Sciences N/A -246.34% -150.81%

Is PAVM or AEMD more profitable?

Aethlon Medical has a net margin of 0.00% compared to PAVmed's net margin of -10,794.64%. Aethlon Medical's return on equity of -123.08% beat PAVmed's return on equity. Company Net Margins Return on Equity Return on Assets PAVmed -10,794.64% -126.43% -25.49% Aethlon Medical N/A -123.08% -99.28%

Does the media prefer AEMD or VVOS?

In the previous week, Aethlon Medical had 4 more articles in the media than Vivos Therapeutics. MarketBeat recorded 9 mentions for Aethlon Medical and 5 mentions for Vivos Therapeutics. Vivos Therapeutics' average media sentiment score of 1.17 beat Aethlon Medical's score of 1.02 indicating that Vivos Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Aethlon Medical 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Vivos Therapeutics 2 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Aethlon Medical (AEMD) Competitors

$2.28 -0.12 (-5.00%)

Closing price 08/26/2026 04:00 PM Eastern

Extended Trading

$2.32 +0.04 (+1.75%)

As of 07:07 AM Eastern

Compare

AEMD vs. AMIX, FEMY, NDRA, PAVM, and VVOS

Should you buy Aethlon Medical stock or one of its competitors? Aethlon Medical's main competitors and comparable companies include Autonomix Medical (AMIX), Femasys (FEMY), ENDRA Life Sciences (NDRA), PAVmed (PAVM), and Vivos Therapeutics (VVOS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Aethlon Medical compare to Autonomix Medical?

Aethlon Medical (NASDAQ:AEMD) and Autonomix Medical (NASDAQ:AMIX) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their risk, institutional ownership, media sentiment, analyst recommendations, earnings, profitability, dividends and valuation.

In the previous week, Aethlon Medical had 2 more articles in the media than Autonomix Medical. MarketBeat recorded 9 mentions for Aethlon Medical and 7 mentions for Autonomix Medical. Aethlon Medical's average media sentiment score of 1.02 beat Autonomix Medical's score of 0.91 indicating that Aethlon Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Autonomix Medical	2 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aethlon Medical's return on equity of -123.08% beat Autonomix Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-123.08%	-99.28%
Autonomix Medical	N/A	-267.73%	-216.75%

Autonomix Medical is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A
Autonomix Medical	N/A	N/A	-$16.72M	-$41.57	N/A

Aethlon Medical currently has a consensus target price of $1.50, suggesting a potential downside of 34.21%. Autonomix Medical has a consensus target price of $42.00, suggesting a potential upside of 558.31%. Given Autonomix Medical's stronger consensus rating and higher possible upside, analysts clearly believe Autonomix Medical is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Autonomix Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

2.0% of Aethlon Medical shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 0.7% of Aethlon Medical shares are owned by company insiders. Comparatively, 6.2% of Autonomix Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Aethlon Medical has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, Autonomix Medical has a beta of -1.17, indicating that its share price is 217% less volatile than the broader market.

Summary

Aethlon Medical beats Autonomix Medical on 8 of the 13 factors compared between the two stocks.

How does Aethlon Medical compare to Femasys?

Aethlon Medical (NASDAQ:AEMD) and Femasys (NASDAQ:FEMY) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, dividends, analyst recommendations, institutional ownership and earnings.

Aethlon Medical has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, Femasys has a beta of -2.08, suggesting that its stock price is 308% less volatile than the broader market.

In the previous week, Aethlon Medical had 2 more articles in the media than Femasys. MarketBeat recorded 9 mentions for Aethlon Medical and 7 mentions for Femasys. Aethlon Medical's average media sentiment score of 1.02 beat Femasys' score of 0.53 indicating that Aethlon Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Femasys	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aethlon Medical has higher earnings, but lower revenue than Femasys. Femasys is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A
Femasys	$2.29M	10.69	-$18.63M	-$3.53	N/A

Aethlon Medical has a net margin of 0.00% compared to Femasys' net margin of -534.36%. Aethlon Medical's return on equity of -123.08% beat Femasys' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-123.08%	-99.28%
Femasys	-534.36%	-225.97%	-74.68%

Aethlon Medical presently has a consensus target price of $1.50, suggesting a potential downside of 34.21%. Femasys has a consensus target price of $50.00, suggesting a potential upside of 1,612.33%. Given Femasys' stronger consensus rating and higher probable upside, analysts plainly believe Femasys is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Femasys	1 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 65.3% of Femasys shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by company insiders. Comparatively, 7.8% of Femasys shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Femasys beats Aethlon Medical on 8 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to ENDRA Life Sciences?

Aethlon Medical (NASDAQ:AEMD) and ENDRA Life Sciences (NASDAQ:NDRA) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, media sentiment, earnings, profitability and dividends.

Aethlon Medical currently has a consensus price target of $1.50, suggesting a potential downside of 34.21%. ENDRA Life Sciences has a consensus price target of $25.00, suggesting a potential upside of 359.56%. Given ENDRA Life Sciences' stronger consensus rating and higher possible upside, analysts clearly believe ENDRA Life Sciences is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
ENDRA Life Sciences	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Aethlon Medical has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, ENDRA Life Sciences has a beta of -0.05, suggesting that its stock price is 105% less volatile than the broader market.

ENDRA Life Sciences is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A
ENDRA Life Sciences	N/A	N/A	-$7.03M	-$6.38	N/A

In the previous week, Aethlon Medical had 8 more articles in the media than ENDRA Life Sciences. MarketBeat recorded 9 mentions for Aethlon Medical and 1 mentions for ENDRA Life Sciences. ENDRA Life Sciences' average media sentiment score of 1.87 beat Aethlon Medical's score of 1.02 indicating that ENDRA Life Sciences is being referred to more favorably in the news media.

Company	Overall Sentiment
Aethlon Medical	Positive
ENDRA Life Sciences	Very Positive

Aethlon Medical's return on equity of -123.08% beat ENDRA Life Sciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-123.08%	-99.28%
ENDRA Life Sciences	N/A	-246.34%	-150.81%

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 1.2% of ENDRA Life Sciences shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by insiders. Comparatively, 10.0% of ENDRA Life Sciences shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

ENDRA Life Sciences beats Aethlon Medical on 7 of the 13 factors compared between the two stocks.

How does Aethlon Medical compare to PAVmed?

PAVmed (NASDAQ:PAVM) and Aethlon Medical (NASDAQ:AEMD) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

In the previous week, Aethlon Medical had 8 more articles in the media than PAVmed. MarketBeat recorded 9 mentions for Aethlon Medical and 1 mentions for PAVmed. PAVmed's average media sentiment score of 1.89 beat Aethlon Medical's score of 1.02 indicating that PAVmed is being referred to more favorably in the media.

Company	Overall Sentiment
PAVmed	Very Positive
Aethlon Medical	Positive

PAVmed currently has a consensus target price of $56.00, indicating a potential upside of 952.63%. Aethlon Medical has a consensus target price of $1.50, indicating a potential downside of 34.21%. Given PAVmed's stronger consensus rating and higher probable upside, equities research analysts clearly believe PAVmed is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
PAVmed	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Aethlon Medical has a net margin of 0.00% compared to PAVmed's net margin of -10,794.64%. Aethlon Medical's return on equity of -123.08% beat PAVmed's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
PAVmed	-10,794.64%	-126.43%	-25.49%
Aethlon Medical	N/A	-123.08%	-99.28%

19.9% of PAVmed shares are held by institutional investors. Comparatively, 2.0% of Aethlon Medical shares are held by institutional investors. 13.4% of PAVmed shares are held by insiders. Comparatively, 0.7% of Aethlon Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

PAVmed has higher revenue and earnings than Aethlon Medical. PAVmed is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
PAVmed	$112K	379.81	$400K	-$16.05	N/A
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A

PAVmed has a beta of 0.54, indicating that its share price is 46% less volatile than the broader market. Comparatively, Aethlon Medical has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market.

Summary

PAVmed beats Aethlon Medical on 10 of the 15 factors compared between the two stocks.

How does Aethlon Medical compare to Vivos Therapeutics?

Aethlon Medical (NASDAQ:AEMD) and Vivos Therapeutics (NASDAQ:VVOS) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, profitability, dividends, risk and analyst recommendations.

Aethlon Medical currently has a consensus price target of $1.50, indicating a potential downside of 34.21%. Vivos Therapeutics has a consensus price target of $2.80, indicating a potential upside of 1,003.23%. Given Vivos Therapeutics' stronger consensus rating and higher possible upside, analysts plainly believe Vivos Therapeutics is more favorable than Aethlon Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Aethlon Medical	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Vivos Therapeutics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Aethlon Medical has a beta of 1.41, meaning that its share price is 41% more volatile than the broader market. Comparatively, Vivos Therapeutics has a beta of 6.22, meaning that its share price is 522% more volatile than the broader market.

In the previous week, Aethlon Medical had 4 more articles in the media than Vivos Therapeutics. MarketBeat recorded 9 mentions for Aethlon Medical and 5 mentions for Vivos Therapeutics. Vivos Therapeutics' average media sentiment score of 1.17 beat Aethlon Medical's score of 1.02 indicating that Vivos Therapeutics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Aethlon Medical	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Vivos Therapeutics	2 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Aethlon Medical has a net margin of 0.00% compared to Vivos Therapeutics' net margin of -122.00%. Aethlon Medical's return on equity of -123.08% beat Vivos Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Aethlon Medical	N/A	-123.08%	-99.28%
Vivos Therapeutics	-122.00%	-2,325.64%	-102.01%

2.0% of Aethlon Medical shares are held by institutional investors. Comparatively, 26.4% of Vivos Therapeutics shares are held by institutional investors. 0.7% of Aethlon Medical shares are held by company insiders. Comparatively, 2.1% of Vivos Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Aethlon Medical has higher earnings, but lower revenue than Vivos Therapeutics. Vivos Therapeutics is trading at a lower price-to-earnings ratio than Aethlon Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aethlon Medical	N/A	N/A	-$7.15M	-$34.97	N/A
Vivos Therapeutics	$17.44M	0.20	-$21.17M	-$1.90	N/A

Summary

Vivos Therapeutics beats Aethlon Medical on 9 of the 15 factors compared between the two stocks.

Get Aethlon Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AEMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

AEMD vs. The Competition

Export

Metric	Aethlon Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.71M	$5.92B	$7.40B	$12.81B
Dividend Yield	N/A	1.75%	2.53%	11.02%
P/E Ratio	-0.07	25.88	272.22	24.11
Price / Sales	N/A	68.58	616.80	85.74
Price / Cash	N/A	33.21	79.89	53.65
Price / Book	0.31	6.24	13.13	6.20
Net Income	-$7.15M	$149.10M	$3.47B	$348.07M
7 Day Performance	-15.56%	0.99%	1.87%	1.02%
1 Month Performance	-19.01%	8.27%	8.05%	4.20%
1 Year Performance	-97.13%	6.61%	26.01%	16.46%

Aethlon Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
AEMD Aethlon Medical	1.4927 of 5 stars	$2.28 -5.0%	$1.50 -34.2%	-97.1%	$1.71M	N/A	N/A	10	Positive News Short Interest Decrease
AMIX Autonomix Medical	2.9741 of 5 stars	$6.17 -3.6%	$42.00 +580.7%	-73.8%	$6.65M	N/A	N/A	1	News Coverage Short Interest Decrease Gap Down
FEMY Femasys	3.4096 of 5 stars	$2.20 +1.9%	$50.00 +2,172.7%	-61.2%	$6.52M	$2.30M	N/A	30	Short Interest Increase
NDRA ENDRA Life Sciences	3.269 of 5 stars	$4.60 +2.4%	$25.00 +443.6%	+33.0%	$5.68M	N/A	N/A	20	Positive News
PAVM PAVmed	2.7736 of 5 stars	$5.06 -4.9%	$56.00 +1,006.7%	-65.8%	$5.18M	$70K	N/A	90	Positive News Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:AEMD) was last updated on 8/27/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Aethlon Medical (AEMD) Competitors

AEMD vs. AMIX, FEMY, NDRA, PAVM, and VVOS

How does Aethlon Medical compare to Autonomix Medical?

Summary

How does Aethlon Medical compare to Femasys?

Summary

How does Aethlon Medical compare to ENDRA Life Sciences?

Summary

How does Aethlon Medical compare to PAVmed?

Summary

How does Aethlon Medical compare to Vivos Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Aethlon Medical (AEMD) Competitors

AEMD vs. AMIX, FEMY, NDRA, PAVM, and VVOS

How does Aethlon Medical compare to Autonomix Medical?

Does the media prefer AEMD or AMIX?

Is AEMD or AMIX more profitable?

Which has preferable earnings and valuation, AEMD or AMIX?

Do analysts recommend AEMD or AMIX?

Do institutionals & insiders have more ownership in AEMD or AMIX?

Which has more volatility & risk, AEMD or AMIX?

Summary

How does Aethlon Medical compare to Femasys?

Which has more risk & volatility, AEMD or FEMY?

Does the media prefer AEMD or FEMY?

Which has higher earnings and valuation, AEMD or FEMY?

Is AEMD or FEMY more profitable?

Do analysts rate AEMD or FEMY?

Do insiders & institutionals hold more shares of AEMD or FEMY?

Summary

How does Aethlon Medical compare to ENDRA Life Sciences?

Do analysts recommend AEMD or NDRA?

Which has more risk and volatility, AEMD or NDRA?

Which has preferable valuation and earnings, AEMD or NDRA?

Does the media prefer AEMD or NDRA?

Is AEMD or NDRA more profitable?

Do insiders and institutionals hold more shares of AEMD or NDRA?

Summary

How does Aethlon Medical compare to PAVmed?

Does the media refer more to PAVM or AEMD?

Do analysts recommend PAVM or AEMD?

Is PAVM or AEMD more profitable?

Do institutionals & insiders believe in PAVM or AEMD?

Which has higher valuation & earnings, PAVM or AEMD?

Which has more volatility and risk, PAVM or AEMD?

Summary

How does Aethlon Medical compare to Vivos Therapeutics?

Do analysts prefer AEMD or VVOS?

Which has more risk and volatility, AEMD or VVOS?

Does the media prefer AEMD or VVOS?

Is AEMD or VVOS more profitable?

Do insiders & institutionals have more ownership in AEMD or VVOS?

Which has stronger earnings & valuation, AEMD or VVOS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

AEMD vs. The Competition

Aethlon Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools